Antiviral Treatment in Patients with Advanced Hcv Cirrhosis Using Sofosbuvir and Ledipasvir/Daclatasvir with or without Ribavirin - 6 and 12 Month Outcomes Compared to Untreated Patients
Cheung, M.C.M, Foster, G.R, Irving, W.L, Walker, A.J, Hudson, B.E, Verma, S, McLauchlan, J, Mutimer, D.J, Brown, A, Gelson, W, MacDonald, D, Agarwal, K
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Effectiveness of Peginterferon Alfa-2a Therapy in HBeAg-Positive and HBeAg-Negative Patients with Chronic Hepatitis B: Final Results 3 Years Post-Treatment of the Prospective, Global, Observational S-Collate Study
Marcellin, P, Xie, Q, Paik, S.W, Flisiak, R, Piratvisuth, T, Petersen, J, Asselah, T, Cornberg, M, Ouzan, D, Foster, G.R, Papatheodoridis, G.V, Messinger, D, Regep, L, Bakalos, G, Alshuth, U, Wedemeyer, H
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Genetic Variation in FCER1A Gene Predicts Sustained HBsAg Clearance in East-Asian Patients Treated with Pegylated Interferon Alfa-2a (40kd): The “Peg-Be-Yond” Study
Wei, L, Pavlovic, V, Bansal, A.T, Chen, X.-P, Foster, G.R, He, H, Kao, J.-H, Lampertico, P, Liaw, Y.-F, Motoc, A, Papatheodoridis, G, Piratvisuth, T, Plesniak, R, Wat, C
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Sofosbuvir-based all-oral regimens for patients with chronic hepatitis C genotype 2 infection: integrated analysis of eleven clinical studies
Zeuzem, S, Han, K.-H, Ahn, S.-H, Lim, Y.-S, Kao, J.-H, Chuang, W.-L, Omata, M, Abramov, F, Crans, G, Llewellyn, J, Natha, M, De-Oertel, S, Brainard, D, Foster, G.R, Gane, E.J, Lawitz, E, Ho, S.B, Jacobson, I.M
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
The safety and tolerability of SOF/VEL/VOX for 8 or 12 weeks in >1,000 patients treated in the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 studies: an integrated analysis
Manns, M, Gane, E.J, Willems, B.E, Roberts, S.K, Flamm, S, Bourliére, M, Asselah, T, Alric, L, Hyland, R.H, Stamm, L.M, Huang, K.C, Brainard, D.M, Khalili, M, Foster, G.R, Gordon, S.C, Reddy, K.R, Zeuzem, S, Jacobson, I.M, Cooper, C.L, Thompson, A.J, Kowdley, K, Lawitz, E
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
SOF/VEL/VOX results in high SVR12 rates when administered for 12 weeks in DAA-experienced patients or for 8 Weeks in DAA-naïve patients: an integrated analysis of the POLARIS-1, POLARIS-2, POLARIS-3 and POLARIS-4 studies
Roberts, S.K, Cooper, C.L, Lawitz, E, Reddy, K.R, Thompson, A.J, Zeuzem, S, Jacobson, I.M, Ruane, P, Hyland, R.H, Stamm, L.M, Han, L, Brainard, D.M, Bräu, N, Asselah, T, Willems, B.E, Flamm, S, Bourlière, M, Foster, G.R, Gane, E.J, Manns, M, Gordon, S.C, Kowdley, K
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
P1190 MODELING THE IMPACT OF EARLY ANTIRETROVIRAL THERAPY FOR ADULTS COINFECTED WITH HIV AND HEPATITIS B OR C IN SOUTH AFRICA
Martin, N.K, Devine, A, Eaton, J.W, Hallett, T.B, Foster, G.R, Dore, G.J, Easterbrook, P.J, Legood, R, Vickerman, P
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1120 PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALS
Zeuzem, S, Demasi, R, Foster, G.R, Buti, M, Baldini, A, Luo, D, Witek, J, Rizzetto, M
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P0908 : Adherence to ombitasvir/paritaprevir/r, dasabuvir, and ribavirin is >98% in the Sapphire-I and Sapphire-II trials
Hassanein, T, Roberts, S, Shafran, S.D, Makara, M, Bennett, M, Müllhaupt, B, Poordad, F, Ryder, S, Di Bisceglie, A.M, Fu, B, Coakley, E, McGovern, B.H, Foster, G.R
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
LO5 : Sofosbuvir + peginterferon/ribavirin for 12 weeks vs sofosbuvir + ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experienced cirrhotic patients with genotype 2 HCV: The boson study
Foster, G.R, Pianko, S, Cooper, C, Brown, A, Forton, D, Nahass, R.G, George, J, Barnes, E, Brainard, D.M, Massetto, B, Lin, M, McHutchison, J.G, Subramanian, G.M, Agarwal, K
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P0808 : Improvement in liver function and non-invasive estimates of liver fibrosis 48 weeks after treatment with ombitasvir/paritaprevir/R, dasabuvir and ribavirin in HCV genotype 1 patients with cirrhosis
Wedemeyer, H, Berg, T, Flamm, S.L, Foster, G.R, Craxi, A, Larrey, D, Morgan, T.R, Fried, M.W, Poordad, F, Trinh, R, Lovell, S, Tang, Y, Pedrosa, M, Lopez-Talavera, J.-C, Jacobson, I.M
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P0792 : Baseline factors associated with increased SVR rates in 123 treatment-naïve chronic HCV genotype 1 patients treated with a shortened 12-week simeprevir plus pegylated interferon and ribavirin regimen: a multivariate analysis
Asselah, T, Moreno, C, Sarrazin, C, Gschwantler, M, Foster, G.R, Craxi, A, Buggisch, P, Ryan, R, Lenz, O, Van Dooren, G, Lonjon-Domanec, I, Schlag, M, Buti, M
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P0474 : Characterisation of the immune profiles of chronic hepatitis B patients following NUC discontinuation by cyTOF mass cytometry
Rivino, L, Van Den Berg, M, Le Bert, N, Koh, S, Gill, U.S, Hansi, N.K, Foster, G.R, Bertoletti, A, Kennedy, P.T
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P0001 : Early monocyte dysfunction in patients who develop Systemic Inflammatory Response Syndrome (SIRS) and sepsis after hepatopancreaticobiliary surgery
Lahiri, R, Derwa, Y, Bashir, Z, Giles, E, Torrance, H, O’Dwyer, M, Owen, H, O’Brien, A, Stagg, A, Bhattacharya, S, Foster, G.R, Alazawi, W
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
High Efficacy of an 8-Week 3-Drug Regimen of Grazoprevir/MK-8408/MK-3682 in HCV Genotype 1, 2 and 3-Infected Patients: SVR24 Data from the Phase 2 C-Crest 1 and 2 Studies
Gane, E.J, Pianko, S, Roberts, S.K, Thompson, A.J, Zeuzem, S, Zuckerman, E, Ari, Z.B, Foster, G.R, Agarwal, K, Laursen, A.L, Gerstoft, J, Gao, W, Huang, H.-C, Fitzgerald, B, Li, J.J, Wan, S, Dutko, F, Nguyen, B.-Y.T, Wahl, J, Barr, E, Butterton, J.R, Esteban, R
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
964 IMPLEMENTING EASL & AASLD GUIDELINES FOR HEPATOCELLULAR CARCINOMA SCREENING IS COST-EFFECTIVE IN LONDON'S ETHNICALLY DIVERSE POPULATION
Alazawi, W, Abeysekera, K, Dearden, J, Glynn, M, Kallis, Y, Kennedy, P, Marley, R, Foster, G.R, Kooner, P
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
746 INDUCTION MAINTENANCE THERAPY IN CHRONIC HEPATITIS B; STEP-DOWN FROM COMBINATION LAMIVUDINE AND TENOFOVIR TO LAMIVUDINE MONOTHERAPY – A POTENTIAL NEW TREATMENT STRATEGY
Gill, U.S, Payaniandy, L, Payaniandy, D, Schulz, J, Ross, V.A, Kallis, Y.N, Kooner, P, Marley, R.T.C, Kennedy, P.T.F, Foster, G.R
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
319 PATIENTS WITH COMPENSATED CIRRHOSIS HAVE SELECTIVE PARESIS OF FLAGELLIN-INDUCED INNATE IMMUNE RESPONSES DUE TO FAILURES IN ERK SIGNALLING
Alazawi, W, Lahiri, R, Spyrou, A, Giles, E, Bashir, Z, O'Brien, A, Stagg, A, Waters, J, Foster, G.R
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
P1167 rs12979860 IL28B GENOTYPE IS ASSOCIATED WITH ADVANCED FIBROSIS IN HCV GENOTYPE 1-INFECTED EUROPEAN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE INTERNATIONAL GEN-C STUDY
Mangia, A, De Ledinghen, V, Bailly, F, Brahm, J, Keiss, J, Valantinas, J, Rasmann, N, Riachi, G, Messinger, D, Caputo, A, Foster, G.R
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
O164 ALL ORAL FIXED-DOSE COMBINATION SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN FOR 12 OR 24 WEEKS IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-1 STUDY
Mangia, A, Marcellin, P, Kwo, P, Foster, G.R, Buti, M, Bräu, N, Muir, A, Yang, J.C, Mo, H, Ding, X, Pang, P.S, Symonds, W.T, McHutchison, J.G, Zeuzem, S, Afdhal, N
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article